Literature DB >> 34257088

Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial.

Manuel R Blum1,2, Bastiaan T G M Sallevelt3, Anne Spinewine4,5, Denis O'Mahony6, Elisavet Moutzouri1,2, Martin Feller1,2, Christine Baumgartner1, Marie Roumet7, Katharina Tabea Jungo2, Nathalie Schwab1,2, Lisa Bretagne1, Shanthi Beglinger1,2, Carole E Aubert1,2,8,9, Ingeborg Wilting3, Stefanie Thevelin4, Kevin Murphy10, Corlina J A Huibers11, A Clara Drenth-van Maanen11, Benoit Boland12,13, Erin Crowley10, Anne Eichenberger14, Michiel Meulendijk15, Emma Jennings6, Luise Adam1,16, Marvin J Roos11, Laura Gleeson10, Zhengru Shen15, Sophie Marien12,13, Arend-Jan Meinders17, Oliver Baretella1,2, Seraina Netzer1,2, Maria de Montmollin1,2, Anne Fournier4, Ariane Mouzon5, Cian O'Mahony10, Drahomir Aujesky1, Dimitris Mavridis18, Stephen Byrne10, Paul A F Jansen3, Matthias Schwenkglenks19, Marco Spruit15,20, Olivia Dalleur4,21, Wilma Knol11, Sven Trelle7, Nicolas Rodondi22,2.   

Abstract

OBJECTIVE: To examine the effect of optimising drug treatment on drug related hospital admissions in older adults with multimorbidity and polypharmacy admitted to hospital.
DESIGN: Cluster randomised controlled trial.
SETTING: 110 clusters of inpatient wards within university based hospitals in four European countries (Switzerland, Netherlands, Belgium, and Republic of Ireland) defined by attending hospital doctors. PARTICIPANTS: 2008 older adults (≥70 years) with multimorbidity (≥3 chronic conditions) and polypharmacy (≥5 drugs used long term). INTERVENTION: Clinical staff clusters were randomised to usual care or a structured pharmacotherapy optimisation intervention performed at the individual level jointly by a doctor and a pharmacist, with the support of a clinical decision software system deploying the screening tool of older person's prescriptions and screening tool to alert to the right treatment (STOPP/START) criteria to identify potentially inappropriate prescribing. MAIN OUTCOME MEASURE: Primary outcome was first drug related hospital admission within 12 months.
RESULTS: 2008 older adults (median nine drugs) were randomised and enrolled in 54 intervention clusters (963 participants) and 56 control clusters (1045 participants) receiving usual care. In the intervention arm, 86.1% of participants (n=789) had inappropriate prescribing, with a mean of 2.75 (SD 2.24) STOPP/START recommendations for each participant. 62.2% (n=491) had ≥1 recommendation successfully implemented at two months, predominantly discontinuation of potentially inappropriate drugs. In the intervention group, 211 participants (21.9%) experienced a first drug related hospital admission compared with 234 (22.4%) in the control group. In the intention-to-treat analysis censored for death as competing event (n=375, 18.7%), the hazard ratio for first drug related hospital admission was 0.95 (95% confidence interval 0.77 to 1.17). In the per protocol analysis, the hazard ratio for a drug related hospital admission was 0.91 (0.69 to 1.19). The hazard ratio for first fall was 0.96 (0.79 to 1.15; 237 v 263 first falls) and for death was 0.90 (0.71 to 1.13; 172 v 203 deaths).
CONCLUSIONS: Inappropriate prescribing was common in older adults with multimorbidity and polypharmacy admitted to hospital and was reduced through an intervention to optimise pharmacotherapy, but without effect on drug related hospital admissions. Additional efforts are needed to identify pharmacotherapy optimisation interventions that reduce inappropriate prescribing and improve patient outcomes. TRIAL REGISTRATION: ClinicalTrials.gov NCT02986425. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Year:  2021        PMID: 34257088     DOI: 10.1136/bmj.n1585

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  18 in total

Review 1.  Long-term recovery after critical illness in older adults.

Authors:  Ramya Kaushik; Lauren E Ferrante
Journal:  Curr Opin Crit Care       Date:  2022-08-11       Impact factor: 3.359

2.  Consensus validation of a screening tool for cardiovascular pharmacotherapy in geriatric patients: the RASP_CARDIO list (Rationalization of Home Medication by an Adjusted STOPP list in Older Patients).

Authors:  Hannah De Schutter; Julie Hias; Laura Hellemans; Karolien Walgraeve; Jos Tournoy; Peter Verhamme; Peter Sinnaeve; Rik Willems; Walter Droogné; Christophe Vandenbriele; Lucas Van Aelst; Thomas Vanassche; Lorenz Van der Linden
Journal:  Eur Geriatr Med       Date:  2022-10-14       Impact factor: 3.269

3.  Drug-Related Hospital Admissions via the Department of Emergency Medicine: A Cross-Sectional Study From the Czech Republic.

Authors:  Zuzana Očovská; Martina Maříková; Jaromír Kočí; Jiří Vlček
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

Review 4.  Polypharmacy and Mental Health Issues in the Senior Hemodialysis Patient.

Authors:  Maša Knehtl; Tadej Petreski; Nejc Piko; Robert Ekart; Sebastjan Bevc
Journal:  Front Psychiatry       Date:  2022-05-12       Impact factor: 5.435

5.  Development of a Metric to Detect and Decrease Low-Value Prescribing in Older Adults.

Authors:  Thomas R Radomski; Alison Decker; Dmitry Khodyakov; Carolyn T Thorpe; Joseph T Hanlon; Mark S Roberts; Michael J Fine; Walid F Gellad
Journal:  JAMA Netw Open       Date:  2022-02-01

6.  A qualitative dual-site analysis of the pharmacist discharge care (PHARM-DC) intervention using the CFIR framework.

Authors:  Logan T Murry; Michelle S Keller; Joshua M Pevnick; Jeffrey L Schnipper; Korey A Kennelty
Journal:  BMC Health Serv Res       Date:  2022-02-12       Impact factor: 2.908

7.  Cost-effectiveness of a structured medication review approach for multimorbid older adults: Within-trial analysis of the OPERAM study.

Authors:  Paola Salari; Cian O'Mahony; Séverine Henrard; Paco Welsing; Arjun Bhadhuri; Nadine Schur; Marie Roumet; Shanthi Beglinger; Thomas Beck; Katharina Tabea Jungo; Stephen Byrne; Stefanie Hossmann; Wilma Knol; Denis O'Mahony; Anne Spinewine; Nicolas Rodondi; Matthias Schwenkglenks
Journal:  PLoS One       Date:  2022-04-11       Impact factor: 3.240

8.  Hospital physicians' and older patients' agreement with individualised STOPP/START-based medication optimisation recommendations in a clinical trial setting.

Authors:  C J A Huibers; B T G M Sallevelt; J M J Op Heij; D O'Mahony; N Rodondi; O Dalleur; R J van Marum; A C G Egberts; I Wilting; W Knol
Journal:  Eur Geriatr Med       Date:  2022-03-15       Impact factor: 3.269

9.  Deprescribing or represcribing: not just a semantic dilemma.

Authors:  Martin Wehling; Mirko Petrovic
Journal:  Eur Geriatr Med       Date:  2022-06       Impact factor: 3.269

10.  Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity.

Authors:  Bastiaan T G M Sallevelt; Corlina J A Huibers; Jody M J Op Heij; Toine C G Egberts; Eugène P van Puijenbroek; Zhengru Shen; Marco R Spruit; Katharina Tabea Jungo; Nicolas Rodondi; Olivia Dalleur; Anne Spinewine; Emma Jennings; Denis O'Mahony; Ingeborg Wilting; Wilma Knol
Journal:  Drugs Aging       Date:  2021-12-08       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.